medigraphic.com
ISSN 1028-4796 (Impreso)

2011, Número 4

<< Anterior

Rev Cubana Plant Med 2011; 16 (4)


Acercamiento al género Murraya (Rutaceae) y a la especie Murraya paniculata (L.) Jack.

Casado MCM, Gutiérrez GYI, Rodríguez AE

Idioma: Español
Referencias bibliográficas: 57
Paginas: 408-418
Archivo PDF: 128.26 Kb.


RESUMEN

Introducción: Murraya paniculata (L.) Jack (Rutaceae) es empleada tradicionalmente en algunas provincias de Cuba para el alivio del dolor y la inflamación asociados a enfermedades osteomioarticulares. No se reportan estudios en el país que profundicen en la composición química de esta especie o del género Murraya, ni tampoco relacionados con información etnomédica y actividades biológicas comprobadas.
Objetivos: reunir y analizar información científica actualizada referente al género, y a esta especie en particular, como fuente natural de compuestos biológicamente activos que determinan sus potencialidades medicinales.
Métodos: se incluyeron en el análisis artículos científicos y libros relacionados con los temas de composición química, usos tradicionales y evaluaciones farmacológicas, así como otros elementos de interés de plantas medicinales.
Resultados: la información analizada puede servir de base para el desarrollo de nuevas investigaciones que avalen el empleo en la terapéutica de productos fitoterápicos de elevada eficacia, seguridad y calidad. La revisión de los resultados de otros grupos de investigación permite establecer estrategias racionales de investigación científica, que contribuyan al uso racional de los recursos que se encuentran en universidades y centros de investigación y salud.
Conclusiones: los elementos encontrados en la bibliografía consultada permiten asegurar que la especie Murraya paniculata puede ser potencialmente empleada en fitoterapia, debido entre otras cosas, al importante número de metabolítos secundarios identificados con actividad farmacológica reconocida.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Farnsworth N, Morris RW. Higher plants-the sleeping giant of drug development. Am J Pharm. 1976;148:46-52.

  2. Akerele O. Who´s traditional medicine programme: progress and perspectives. Who Chron. 1984;38:78-81.

  3. Sharapin N, Machado L, Souza E, de Albuquerque E, Valverde E, López JM. Fundamentos de tecnología de productos fitoterapéuticos. Santa Fe de Bogotá. Colombia: Ed. Convenio Andrés Bello y Red Iberoamericana de Productos Fitofarmacéuticos (RIPROFITO) del Subprograma X de CYTED; 2000. p. 17.

  4. Attiso MA. Aproveche scientifique rationnelle des medication traditionelles despays en voie de developpement en vue d´une Phytotherapie renové. DPM/78. Ginebra: OMS ; 1978.

  5. Grûnewald J. The emerging role of herbal medicine in health care in Europe. Drug Inf. J. 2000;32:151-153.

  6. World Health Organization. General Guidelines for methodologies on research and evaluation of traditional medicine. WHO/EDM/TRM/2000.1. Geneva, Suiza: WHO; 2000. p. 5.

  7. World Health Organization. Repor of the Inter-Regional Workshop on Intellectual Property Rights in the Context of Traditional Medicine. WHO/EDM/TRM/2000.1. Bangkok, Thailand: WHO; 2000. p. 2.

  8. Wikipedia. La Enciclopedia libre; 2009. Disponible en: http://es.wikipedia.org/wiki/Rutaceae

  9. Chase MW, Cynthia MM, Kallunki JA. Phylogenetic relationship or Rutaceae: a cladistic analysis of the subfamilies using evidence from RBC and ATP sequence variation. Am J Botany. 1999;86(8):1191-9.

  10. Singh G. Plant systematic. An integrated approach. New Hampshire: Science Publisher; 2004. p. 438-40.

  11. Annual Proceedings of the Phytochemical Society of Europe. vol. 22; 1983.

  12. Murphy W, Bertrand M. Bromoquinoneenaminone annulations: syntheses of murrayaquinone-A and (±)-bismurrayaquinone-A. J Chemical Society Perkin Trans. 1998;1:4115-9.

  13. Wikipedia. La Enciclopedia libre;2009. Disponible en: http://es.wikipedia.org/wiki/Murraya

  14. Chang CE. Flora of Taiwan. Vol. 3. China: Epoch Publishing Co.; 1977. p. 520-3.

  15. Walter HL, Memory PF. Medicinal plants affecting man's health. New York: John Wiley; 1977. p. 243.

  16. Perry LM, Metzger J. Medicinal plants of east and Southeast Asia: attributed properties and uses. Cambridge, England: the MIT Press; 1980. p. 367.

  17. Negi N, Ochi A, Kurosawa M, Ushijima K, Kitaguchi Y, Kusakabe E, et al. Two new dimeric coumarins isolated from Murraya exotica. Chem Pharm Bull. 2005;53(9):1180-2.

  18. Chevallier A. The Encyclopedia of Medicinal Plants. London, New York, Stuttgart, Moscow: Dorling Kindersley; 1996.

  19. Tachibana Y, Kikuzaki H, Lajis N, Nakatani N. Antioxidative activity of carbazoles from Murraya koenigii leaves. J Agric Food Chem. 2001;49(11):5589- 94.

  20. Anonymous. The wealth of India: The raw materials. Vol. 6, India: CSIR; 1962. p. 446-8.

  21. Hiremath SM, Madalageri BB, Basarkar PW. Composition of curry leaf (Murraya koenigii Spreng) oil during leaf growth. Indian Perfum. 1998;42:58-9.

  22. Min HM, Aye M, Taniguchi T, Miura N, Monde K, Ohzawa K, et al. A structure and an absolute configuration of (+)-alternamin, a new coumarin from Murraya alternans having antidote activity against snake venom. Tetrahedron Letters. 2007;48:6155-8.

  23. Ito C, Itoigawa M, Onoda S, Hosokawa A, Ruangrungsi N, Okuda T, et al. Chemical constituents of Murraya siamensis: three coumarins and their anti-tumor promoting effect. Phytochemistry. 66:567-72.

  24. Chakrabarty M, Nath A, Khasnobis AS, Konda Y, Harigaya Y, Komiyama K. Carbazole alkaloids from Murraya koenigii. J Phytochemistry. 2005;46:751-5.

  25. Myoe H. A structure and an absolute configuration of (+)- alternamin, a new coumarin from Murraya alternans having antidote activity against snake venom. Tetrahedron Letters. 2007;48:6155-8.

  26. Chia YC, Chang FR, Wang JC, Wu CC, Chiang MY, Lan YH, et al. Antiplatelet aggregation coumarins from the leaves of Murraya omphalocarpa. Molecules. 2008;13(1):122-8.

  27. Dasgupta T, Rao AR, Yadava PK. Chemomodulatory action of curry leaf (Murraya koenigii) extract on hepatic and extrahepatic xenobiotic metabolising enzymes, antioxidant levels, lipid peroxidation, skin and forestomach papillomagenesis. Nutrition Research. 2003;23:1427-46.

  28. Ningappa M, Dinesha R, Srinivas L. Antioxidant and free radical scavenging activities of polyphenol-enriched curry leaf (Murraya koenigii L.) extracts. Food Chemistry. 2008;106:720-8.

  29. Yadav S, Vats V, Dhunnoo Y, Grover JK. Hypoglycemic and antihyperglycemic activity of Murraya koenigii leaves in diabetic rats. J Ethnopharmacol. 2002;82:111-6.

  30. Nigam SS, Purohit RM. Chemical examination of the essential oil derived from the leaves of Murraya koenigii (Linn.) Spreng. (Indian curry leaf). Perfum Ess Oil Rec. 1961;11:152-5.

  31. Prakesh V, Natarajan CP. Studies on curry leaf (Murraya koenigii L.). J Food Sci Tech. 1974;11:285-6.

  32. MacLeod AJ, Pieris NM. Analysis of the essential oil of Murraya koenigii and Pandanus latifollus. Phytochemistry. 1982;21:1653-8.

  33. Uddin JC, Islam MNB, Yusuf M. Chemical composition of the leaf essential oils of Murraya koenigii (L.) Spreng and Murraya paniculata (L.) Jack. Bangladesh J Pharmacol. 2008;3:59-63.

  34. Raina VK, Lal RK, Tripathi S, Khan M, Syamasundar KV, Srivastava SK. Essential oil composition of genetically diverse stocks of Murraya koenigii from India. Flav Frag J. 2002;17:144-6.

  35. Walde GS, Joythirmay T, Rao P, Shivaswamy R, Srinivas P. Flavour volatiles of leaves, fruits and seed cotyledons of Murraya koenigii L. Flav Frag J. 2005;20:169-72.

  36. Jagadeesh S, Sinha S, Pal B, Bhattacharya S, Banerjee P. Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells. Biochem Biophysical Research Communications. 2007;362:212-7.

  37. El-Sakhawy F, El-Tantawy M, Ross S, El-Sohly M. Composition and antimicrobial activity of the essential oil of Murraya exotica L. Flavour Fragrance J. 1998;13:59-62.

  38. Little EL Jr., Woodbury RO, Wadsworth FH. Trees of Puerto Rico and the Virgin Islands. Vol. 2. U.S. Department of Agriculture, Washington, DC: Agriculture Handbook.1974;2:10-24.

  39. Roig JT. Diccionario botánico de nombres vulgares cubano. La Habana: Editorial Científico-Técnica; 1988. p. 695.

  40. Bhatterjee SK. Hand book of aromatic plants. India: popular offset services Pvt. Ltd., Jaipur 302004; 2000. p. 299.

  41. Parrotta JA. Healing plants of Peninsular India. Wallingford, UK and New York: CABI Publishing; 2001. p. 917

  42. Neal MC. In gardens of Hawaii. Special Publication 50. Bernice P. Bishop, editor Honolulu, HI: Museum Press; 1965. p. 924.

  43. Pacific Island Ecosystems at Risk. Invasive plant species: Murraya paniculata (L.) Jack, Rutaceae; 2002. p. 2. Disponible en: http://www.hear.org/pier/species/murraya_paniculata.htm

  44. Desert-Tropicals. Orange jasamine; 2002. Disponible en: http://www.deserttropicals. com/Plants/Rutaceae/Murraya_paniculata.html

  45. Ghani A. Medicinal plants of Bangladesh: Chemical constituents and uses. 2nd Asiatic Society of Bangladesh: ed. Dhaka; 2003. p 309-10.

  46. Rout PK, Rao YR, Sree A, Naik, SN. Composition of essential oil, concrete, absolute, wax and headspace volatiles of Murrarya paniculata (L.) Jack flowers. Flavour Fragr J. 2007;22:352-7.

  47. Olawore NO, Ogunwande IA, Ekundayo O, Adeleke KA. Chemical composition of the leaf and fruit essential oils of Murraya paniculata (L.) Jack. (Syn. Murraya exotica L.). Flav Frag J. 2004;20:54-6.

  48. Lastbom L, Boman A, Camner P, Ryrfeldt A. Does airway responsiveness increase after skin sensitization to 3-carene: a study in isolated guinea pig lungs. Toxicology. 1998;125:59-66.

  49. Jeong JG, Kim YS, Min TY, Kim SH. Low concentration of 3-carene stimulates the differentiation of mouse osteoblastic MC3T3-E1 subclone 4 cells. Phytotherapy Res. 2007;22:18-22.

  50. Dash GK, Patro CP, Maiti AK. Anti-inflammatory and analgesic activity of leaf essential oil from Murraya koenigii Spreng. Hamdard Medicus. 2004;47:22-6.

  51. Sawangjaroen N, Phongpaichit S, Subhadhirasakul S, Visutthi M, Srisuwan N, Thammapalerd N. The anti-amoebic activity of some medicinal plants used by AIDS patients in southern Thailand. Parasitol Res. 2006;98:588-92.

  52. Kong YC, Cheng KF, Cambie RC, Watermand PG. Yuehchukene: a novel lndole alkaloid with anti-implantation activity. J Chem Soc Chem Commun. 1985;47-8. Disponible en: http://pubs.rsc.org/en/content/articlepdf/1985/c3/c39850000047

  53. Kinoshita T, Firman K. Highly oxygenated flavonoids from Murraya paniculata. Phytochemistry. 1996;42:1207-10.

  54. Ito C, Furukawa H. The Chemical Composition of Murraya paniculata. The Structure of Five New Coumarins and One New Alkaloid and the Stereochemistry of Murrangatin and Related Coumarins. J Chem Soc Perkin Trans. 1990;1:2047-55.

  55. Saied S, Uddin S. 1', 2'-o-isopropylidene murrangatin from Murraya paniculata. J Basic Applied Sciences. 2008;4(1):13-5.

  56. Kinoshita T, Shimada M. Isolation and structure elucidation of a new prenylcoumarin from Murraya paniculata var. omphalocarpa (Rutaceae). Chem Pharm Bull. 2002;50(1):118-20.

  57. Ferracin R, Das F, João DS, Vieira P. Flavonoids from the fruits of Murraya paniculata. Phytochemistry. 1998;47(3):393-6.




2020     |     www.medigraphic.com